Table 6 Clinical characteristics of COPD patients with PPCs (+) or (−)
From: Risk factors of postoperative pulmonary complications in patients with asthma and COPD
Variables | PPC (+) n = 7 | PPC (−) n = 82 | p-value |
|---|---|---|---|
gender, male / female | 7 / 0 | 68 / 14 | 0.59‡ |
age, years | 77.3 ± 7.9 | 70.0 ± 8.1 | 0.034†|
BMI, kg/m2 | 23.8 ± 2.6 | 23.0 ± 3.0 | 0.66†|
Smoking Index, pack-years | 40.7 ± 8.6 | 48.2 ± 34.7 | 0.88†|
%VC, % | 104.8 ± 15.5 | 104.0 ± 21.0 | 0.99†|
%FEV1, % | 89.5 ± 11.0 | 84.1 ± 21.7 | 0.34†|
GOLD stage (1/2/3/4) | 6/1/0/0 | 41/34/6/1 | 0.39* |
Peripheral blood eosinophil, /mm3 | 210 ± 97 | 187 ± 135 | 0.38†|
COPD treatment, y/n | 3 / 4 | 63 / 19 | 0.07‡ |
ASA-PS, 1/2/3- | 1 / 5 / 1 | 7 / 62 / 13 | 0.88* |
Upper abdominal surgery, y/n | 2 / 5 | 5 / 75 | 0.14‡ |
Laparoscopic surgery, y/n | 1 / 6 | 15 / 67 | >0.99‡ |
Operation time, min | 393 ± 149 | 196 ± 131 | 0.002†|